Clinical Trial Update: Evaluation of SC-V Versus Conventional CPR [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating SC-V versus conventional CPR has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmia
• Cardiac Arrest
• Cardiovascular Diseases
• Cerebral Anoxia
• Heart Disease
• Myocardial Infarction
• Ventricular Fibrillation

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Arrhythmia, Cardiovascular Diseases | Phase 3 | Status: COMPLETED